Maintenance of glutathione levels and its importance in epigenetic regulation

Frontiers in Pharmacology

Volumn 5 MAY, Issue , 2014, Pages

  García Giménez, José L ^a,b,c   Pallardó, Federico V ^a,b,c  

^a CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^b Instituto Universitario IVI INCLIVA   (Spain)

^c UNIVERSITY OF VALENCIA   (Spain)

Author keywords

DNA methylation; Epigenetic regulation; Glutathione; Glutathionylation; Mental disorders; Prodrugs; S adenosyl methionine

Indexed keywords

ASCORBIC ACID; DNA; DNA METHYLTRANSFERASE; DOXORUBICIN; GLUTAREDOXIN; GLUTATHIONE; GLUTATHIONE DISULFIDE; HISTONE H3; HISTONE METHYLTRANSFERASE; HOMOCYSTEINE; METHIONINE; METHIONINE ADENOSYLTRANSFERASE; METHIONINE ADENOSYLTRANSFERASE 1A; METHIONINE SULFOXIDE; METHIONINE SULFOXIDE REDUCTASE; METHIONINE SYNTHASE; S ADENOSYLMETHIONINE; UNCLASSIFIED DRUG;

ALPHA HELIX; AUTISM; BIPOLAR DISORDER; BREAST CANCER CELL LINE; CANCER RESISTANCE; DNA METHYLATION; DNA SEQUENCE; DRUG HALF LIFE; EPIGENETICS; GLUTATHIONE METABOLISM; HISTONE METHYLATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NOTE; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PROTEIN PROCESSING; SCHIZOPHRENIA;

EID: 84904610478     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2014.00088     Document Type: Note

References (28)

1. Anderson, M. E., and Luo, J. L. (1998). Glutathione therapy: from prodrugs to genes. Semin. Liver Dis. 18, 415-424. doi: 10.1055/s-2007-1007174.
2. Cacciatore, I., Cornacchia, C., Pinnen, F., Mollica, A., and Di Stefano, A. (2010). Prodrug approach for increasing cellular glutathione levels. Molecules 15, 1242-1264. doi: 10.3390/molecules15031242.
3. Castagna, A., Le Grazie, C., Accordini, A., Giulidori, P., Cavalli, G., Bottiglieri, T., et al. (1995). Cerebrospinal fluid S-adenosylmethionine (SAMe) and glutathione concentrations in HIV infection: effect of parenteral treatment with SAMe. Neurology 45, 1678-1683. doi: 10.1212/WNL.45.9.1678.
4. Chen, J., Guo, L., Zhang, L., Wu, H., Yang, J., Liu, H., et al. (2013). Vitamin C modulates TET1 function during somatic cell reprogramming. Nat. Genet. 45, 1504-1509. doi: 10.1038/ng.2807.
5. de Luca, A., Moroni, N., Serafino, A., Primavera, A., Pastore, A., Pedersen, J. Z., et al. (2011). Treatment of doxorubicin-resistant MCF7/Dx cells with nitric oxide causes histone glutathionylation and reversal of drug resistance. Biochem. J. 440, 175-183. doi: 10.1042/BJ20111333.
6. Ehrlich, K., Viirlaid, S., Mahlapuu, R., Saar, K., Kullisaar, T., Zilmer, M., et al. (2007). Design, synthesis and properties of novel powerful antioxidants, glutathione analogues. Free Radic. Res. 41, 779-787. doi: 10.1080/10715760701348611.
7. Frey, B. N., Andreazza, A. C., Kunz, M., Gomes, F. A., Quevedo, J., Salvador, M., et al. (2007). Increased oxidative stress and DNA damage in bipolar disorder: a twin-case report. Prog. Neuropsychopharmacol. Biol. Psychiatry 31, 283-285. doi: 10.1016/j.pnpbp.2006.06.011.
8. García-Giménez, J. L., Markovic, J., Dasi, F., Queval, G., Schnaubelt, D., Foyer, C. H., et al. (2013a). Nuclear glutathione. Biochim. Biophys. Acta 1830, 3304-3316. doi: 10.1016/j.bbagen.2012.10.005.
9. García-Giménez, J. L., Olaso, G., Hake, S. B., Bonisch, C., Wiedemann, S. M., Markovic, J., et al. (2013b). Histone h3 glutathionylation in proliferating mammalian cells destabilizes nucleosomal structure. Antioxid. Redox Signal. 19, 1305-1320. doi: 10.1089/ars.2012.5021.
10. James, S. J., Cutler, P., Melnyk, S., Jernigan, S., Janak, L., Gaylor, D. W., et al. (2004). Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am. J. Clin. Nutr. 80, 1611-1617.
11. James, S. J., Melnyk, S., Jernigan, S., Cleves, M. A., Halsted, C. H., Wong, D. H., et al. (2006). Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism. Am. J. Med. Genet. B Neuropsychiatr. Genet. 141B, 947-956. doi: 10.1002/ajmg.b.30366.
12. Kawai, K., Li, Y. S., Song, M. F., and Kasai, H. (2010). DNA methylation by dimethyl sulfoxide and methionine sulfoxide triggered by hydroxyl radical and implications for epigenetic modifications. Bioorg. Med. Chem. Lett. 20, 260-265. doi: 10.1016/j.bmcl.2009.10.124.
13. Kim, H. Y. (2012). Glutaredoxin serves as a reductant for methionine sulfoxide reductases with or without resolving cysteine. Acta Biochim. Biophys. Sin. 44, 623-627. doi: 10.1093/abbs/gms038.
14. Kuratomi, G., Iwamoto, K., Bundo, M., Kusumi, I., Kato, N., Iwata, N., et al. (2008). Aberrant DNA methylation associated with bipolar disorder identified from discordant monozygotic twins. Mol. Psychiatry 13, 429-441. doi: 10.1038/sj.mp.4002001.
15. Lewandowska, J., and Bartoszek, A. (2011). DNA methylation in cancer development, diagnosis and therapy-multiple opportunities for genotoxic agents to act as methylome disruptors or remediators. Mutagenesis 26, 475-487. doi: 10.1093/mutage/ger019.
16. Markovic, J., García-Giménez, J. L., Gimeno, A., Viña, J., and Pallardó, F. V. (2010). Role of glutathione in cell nucleus. Free Radic. Res. 44, 721-733 doi: 10.3109/10715762.2010.485989.
17. Martinez-Chantar, M. L., and Pajares, M. A. (1996). Role of thioltransferases on the modulation of rat liver S-adenosylmethionine synthetase activity by glutathione. FEBS Lett. 397, 293-297. doi: 10.1016/S0014-5793(96)01201-X.
18. Mato, J. M., Corrales, F. J., Lu, S. C., and Avila, M. A. (2002). S-Adenosylmethionine: a control switch that regulates liver function. FASEB J. 16, 15-26. doi: 10.1096/fj.01-0401rev.
19. Minor, E. A., Court, B. L., Young, J. I., and Wang, G. (2013). Ascorbate induces ten-eleven translocation (Tet) methylcytosine dioxygenase-mediated generation of 5-hydroxymethylcytosine. J. Biol. Chem. 288, 13669-13674. doi: 10.1074/jbc.C113.464800.
20. Muratore, C. R., Hodgson, N. W., Trivedi, M. S., Abdolmaleky, H. M., Persico, A. M., Lintas, C., et al. (2013). Age-dependent decrease and alternative splicing of methionine synthase mRNA in human cerebral cortex and an accelerated decrease in autism. PLoS ONE 8:e56927. doi: 10.1371/journal.pone.0056927.
21. Outteryck, O., de Seze, J., Stojkovic, T., Cuisset, J. M., Dobbelaere, D., Delalande, S., et al. (2012). Methionine synthase deficiency: a rare cause of adult-onset leukoencephalopathy. Neurology 79, 386-388. doi: 10.1212/WNL.0b013e318260451b.
22. Pajares, M. A., Duran, C., Corrales, F., Pliego, M. M., and Mato, J. M. (1992). Modulation of rat liver S-adenosylmethionine synthetase activity by glutathione. J. Biol. Chem. 267, 17598-17605.
23. Pallardó, F. V., Markovic, J., Garcia, J. L., and Viña, J. (2009). Role of nuclear glutathione as a key regulator of cell proliferation. Mol. Aspects Med. 30, 77-85. doi: 10.1016/j.mam.2009.01.001.
24. Regland, B., Johansson, B. V., and Gottfries, C. G. (1994). Homocysteinemia and schizophrenia as a case of methylation deficiency. J. Neural Transm. Gen. Sect. 98, 143-152. doi: 10.1007/BF01277017.
25. Sheh, L., Chen, B. L., and Chen, C. F. (1990). Synthesis of cyclic peptide homologs of glutathione as potential antitumor agents. Int. J. Pept. Protein Res. 35, 55-62. doi: 10.1111/j.1399-3011.1990.tb00721.x.
26. Shibata, S., Tominaga, K., and Watanabe, S. (1995). Glutathione protects against hypoxic/hypoglycemic decreases in 2-deoxyglucose uptake and presynaptic spikes in hippocampal slices. Eur. J. Pharmacol. 273, 191-195. doi: 10.1016/0014-2999(94)00727-O.
27. Wu, J. H., and Batist, G. (2013). Glutathione and glutathione analogues; therapeutic potentials. Biochim. Biophys. Acta 1830, 3350-3353. doi: 10.1016/j.bbagen.2012.11.016.
28. Yao, J. K., Leonard, S., and Reddy, R. (2006). Altered glutathione redox state in schizophrenia. Dis. Markers 22, 83-93. doi: 10.1155/2006/248387.